OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug reprofiling history and potential therapies against Parkinson’s disease
Komal Latif, Aman Ullah, Anastasiia D. Shkodina, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14

Showing 14 citing articles:

Antibiotics: From Mechanism of Action to Resistance and Beyond
Shyamalima Saikia, Pankaj Chetia
Indian Journal of Microbiology (2024) Vol. 64, Iss. 3, pp. 821-845
Closed Access | Times Cited: 11

Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review
A. Rodger, Maryam N. ALNasser, Wayne G. Carter
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11022-11022
Open Access | Times Cited: 20

Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 5

Gut microbiota and Parkinson’s Disease: a new frontier in understanding neurological health
Nidhi Kumari, Veeranjaneyulu Addepalli, A. J. More, et al.
Inflammopharmacology (2025)
Closed Access

Synergistic combination of carvedilol, amlodipine, amitriptyline, and antibiotics as an alternative treatment approach for the susceptible and multidrug-resistant A. baumannii infections via drug repurposing
Erennur Ugurel, Dilek Turgut‐Balik
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 9, pp. 1063-1072
Closed Access | Times Cited: 5

Synergizing drug repurposing and target identification for neurodegenerative diseases
Mehar Sahu, Shrutikirti Vashishth, Neha Kukreti, et al.
Progress in molecular biology and translational science (2024), pp. 111-169
Closed Access | Times Cited: 1

Some Aspects and Convergence of Human and Veterinary Drug Repositioning
Patrik Mag, Melinda Nemes-Terényi, Ákos Jerzsele, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4475-4475
Open Access | Times Cited: 1

Influence of sleep quality, excessive daytime sleepiness, circadian features and motor subtypes on depressive symptoms in Parkinson’s disease
Anastasiia D. Shkodina, К. А. Tarianyk, M. Yu. Delva, et al.
Sleep Medicine (2024) Vol. 125, pp. 57-64
Open Access | Times Cited: 1

Molecular docking analysis of MCL-1 inhibitors for breast cancer management
Alzahrani Abdulrahman, Mohammad Azhar Kamal, Akber Asif Hussain, et al.
Bioinformation (2023) Vol. 19, Iss. 6, pp. 707-712
Open Access | Times Cited: 2

Pharmacokinetics and Dose Proportionality Study of a Novel Antiparkinsonian Agent, a 1H-1,2,4-Triazol-3-ylthio-conjugate of Prottremine
Daria S. Gorina, Anastasiya V. Lastovka, Artem D. Rogachev, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4498-4498
Open Access

PROGNOSTIC VALUES OF CIRCADIAN RHYTHM AND SLEEP PARAMETERS IN ASSESSMENT OF STATE ANXIETY IN PARKINSON’S DISEASE WITH REGARD TO MOTOR SUBTYPE
Anastasiia D. Shkodina, К. А. Tarianyk, M. Yu. Delva
Eastern Ukrainian Medical Journal (2024) Vol. 12, Iss. 3, pp. 286-295
Open Access

Repurposing, effects, design, and discovery of drugs in systems biology
Elham Amjad, Babak Sokouti
Elsevier eBooks (2024), pp. 305-318
Closed Access

Page 1

Scroll to top